{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:20:50Z","timestamp":1760170850109},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.humpath.2013.10.010","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T16:41:34Z","timestamp":1382546494000},"page":"481-487","source":"Crossref","is-referenced-by-count":11,"title":["Insulin-like growth factor II messenger RNA\u2013binding protein 3 expression in gastrointestinal mesenchymal tumors"],"prefix":"10.1016","volume":"45","author":[{"given":"Hidetaka","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Arakaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Morimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Zaitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Kohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minako","family":"Hirahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Motoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Oshiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2013.10.010_bb0005","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1200\/JCO.2004.05.140","article-title":"Biology of gastrointestinal stromal tumors","volume":"22","author":"Corless","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1053\/hupa.2002.123545","article-title":"Diagnosis of gastrointestinal stromal tumors: a consensus approach","volume":"33","author":"Fletcher","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0015","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.2012.347","article-title":"One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial","volume":"307","author":"Joensuu","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.humpath.2013.10.010_bb0020","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","article-title":"KIT gene mutations and copy number in melanoma subtypes","volume":"14","author":"Beadling","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2013.10.010_bb0025","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/MCB.19.2.1262","article-title":"A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development","volume":"19","author":"Nielsen","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0030","doi-asserted-by":"crossref","first-page":"31145","DOI":"10.1074\/jbc.M111.263913","article-title":"RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation","volume":"286","author":"Liao","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2013.10.010_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0925-4773(99)00160-4","article-title":"Expression of the highly conserved RNA binding protein KOC in embryogenesis","volume":"88","author":"M\u00fceller-Pillasch","year":"1999","journal-title":"Mech Dev"},{"key":"10.1016\/j.humpath.2013.10.010_bb0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/01.pas.0000149688.98333.54","article-title":"KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas","volume":"29","author":"Yantiss","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0045","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.humpath.2012.12.020","article-title":"Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm","volume":"44","author":"Morimatsu","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0050","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1470-2045(06)70732-X","article-title":"Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study","volume":"7","author":"Jiang","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0055","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.22459","article-title":"RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma","volume":"48","author":"Jeng","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2013.10.010_bb0060","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.humpath.2007.12.012","article-title":"Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors","volume":"39","author":"Li","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0065","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/PAS.0b013e318218985b","article-title":"Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation","volume":"35","author":"Shi","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/modpathol.3801016","article-title":"IMP-3 is a novel progression marker in malignant melanoma","volume":"21","author":"Pryor","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0075","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.humpath.2011.12.020","article-title":"Oncofetal protein IMP3: a useful diagnostic biomarker for leiomyosarcoma","volume":"43","author":"Cornejo","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0080","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.humpath.2009.05.003","article-title":"IMP-3 is differentially expressed in normal and neoplastic lymphoid tissue","volume":"40","author":"King","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0085","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/PAS.0b013e3181a5a207","article-title":"Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor: a comparative clinicopathologic study","volume":"33","author":"Yamamoto","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0090","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/PAS.0b013e3182206f15","article-title":"KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases","volume":"35","author":"Yamamoto","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0095","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Curtin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0100","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1001\/jama.2011.746","article-title":"KIT as a therapeutic target in metastatic melanoma","volume":"305","author":"Carvajal","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.humpath.2013.10.010_bb0105","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/sj.bjc.6604791","article-title":"Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas","volume":"99","author":"Satzger","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2013.10.010_bb0110","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.humpath.2011.08.005","article-title":"c-kit gene mutation and CD117 expression in human anorectal melanomas","volume":"43","author":"Ni","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0115","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/modpathol.2009.116","article-title":"Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous\/mucosal type","volume":"22","author":"Torres-Cabala","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0120","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/PAS.0b013e3181238cec","article-title":"A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors","volume":"32","author":"Espinosa","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0125","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1309\/AJCP9KHD7DCHWLMO","article-title":"Gastrointestinal stromal tumor markers in cutaneous melanomas: relationship to prognostic factors and outcome","volume":"136","author":"Gonzalez","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0130","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2559.2011.04150.x","article-title":"Discovered on gastrointestinal stromal tumours 1 (DOG1) expression in non-gastrointestinal stromal tumour (GIST) neoplasms","volume":"61","author":"Hemminger","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2013.10.010_bb0135","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/PAS.0b013e31818371fc","article-title":"True smooth muscle tumors of the small intestine: a clinicopathologic, immunohistochemical, and molecular genetic study of 25 cases","volume":"33","author":"Miettinen","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/his.12159","article-title":"Clinicopathological features of primary leiomyosarcoma of the gastrointestinal tract following recognition of gastrointestinal stromal tumours","volume":"63","author":"Yamamoto","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2013.10.010_bb0145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00428-004-1055-8","article-title":"Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis","volume":"445","author":"Yamaguchi","year":"2004","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2013.10.010_bb0150","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/jcp.2007.049387","article-title":"Inflammatory myofibroblastic tumours: where are we now?","volume":"61","author":"Gleason","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2013.10.010_bb0155","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/PAS.0b013e318200cfd5","article-title":"Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK","volume":"35","author":"Mari\u00f1o-Enr\u00edquez","year":"2011","journal-title":"Am J Surg Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713004255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713004255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T12:20:58Z","timestamp":1539260458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817713004255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0046817713004255"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2013.10.010","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}